4.5 Article

Short communication: Ex-vivo effects of fluoxetine on production of biomarkers for inflammation and neurodevelopment by the placenta

Journal

PLACENTA
Volume 107, Issue -, Pages 46-50

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.placenta.2021.02.018

Keywords

SSRI; Depression; Fluoxetine; Inflammation; Infection; Host-immune response

Ask authors/readers for more resources

Fluoxetine prescribed during pregnancy can lead to sex-specific behavioral changes in offspring, similar to infections. The drug has significant sex- and infection-dependent effects on BDNF production in placenta explant cultures. Further studies are needed to investigate these effects in vivo and their impact on pregnancy and neurodevelopment outcomes.
Fluoxetine is commonly prescribed during pregnancy but developmental exposure to the drug, like infection, is associated with sex-specific behavioral changes in the offspring. We evaluated the effects of Fluoxetine on production of biomarkers for inflammation (pro/anti-inflammatory cytokines) and neurodevelopment (Brain-Derived Neurotrophic Factor, BDNF) in the presence and absence of infection in female and male placenta explant cultures. In addition to minor anti-inflammatory effects of the drug, Fluoxetine had significant sex- and infection-dependent effects on BDNF production. Further studies are needed to determine the extent to which these observed changes occur in vivo and their impact on pregnancy and neurodevelopmental outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available